Administering specialty drugs in physicians’ offices and patients’ homes instead of in-hospital could improve care and cut healthcare spending in the U.S. by $4 billion each year, according to a Sept. 9 report from UnitedHealth Group.
Healthcare consumers see AI-delivered healthcare as standardized and therefore neglectful of patients’ individual needs, which is one reason they tend to be less accepting of healthcare delivered by AI than that provided by humans.
Advancing its interest in AI for smart homes, Google has filed a patent for AI technology that would monitor babies by tracking their vocalizations as well as their eye and body movements.
While much of the attention paid to AI in healthcare has focused on applications to improve care and the administration thereof, industry players have quietly begun tapping the technology to boost sales of their healthcare wares.
Kaiser Permanente, a large health system based in California, will be forced to follow the same disclosure laws as other healthcare payers and providers in the state thanks to a new law signed by Gov. Gavin Newsom.
Amid an outbreak of hundreds of lung disease illnesses and two deaths related to e-cigarette use, investigators from the New York State Department of Health may have finally determined what is making people so sick across the country. Vitamin E acetate has become the focus of the Department after it was found in nearly all cannabis-containing samples analyzed by its investigation.
